
Fake Medicine Sale In Odisha: Glenmark Issues Advisory On How To Know Originality
Bhubaneswar: In the wake of distribution and sale of its duplicate products in Odisha, pharmaceutical company Glenmark has advised the people to purchase medicines only from authorised drug stores and chemists.
In an advisory issued by the company on Thursday, the pharma major condemned duplication of medicines Telma 40 and Telma AM, produced by it. “We at Glenmark, strongly condemn the counterfeiting of our products, Telma 40 and Telma AM in Cuttack, Odisha. We are a responsible corporate citizen and pride ourselves on patient safety. In that respect, we are taking all necessary measures, including closely working with the government authorities, to address this counterfeiting menace,” the company said.
Related Posts
Anti-Counterfeiting Packaging Market – Global Market Size, Industry Analysis, Share, Growth, Trends and Forecast 2014 – 2020
Anti-counterfeiting is a measure implemented to prevent illegal imitation or...
Combating counterfeiters could soon be as easy as breathing
Researchers at the University of Michigan have developed an iridescent material...
Cigarettes, gold most smuggled items in Gujarat
Ahmedabad: Estimates by officials of Directorate of Revenue Intelligence (DRI) -...
Milton Keynes man Ernestas Vadeikis avoids jail for role in illegal tobacco smuggling rings
A Milton Keynes man who was part of illegal tobacco smuggling rings in...

